Patient with Down syndrome and relapsed acute lymphoblastic leukemia
with sustained remission despite only partial British R3 chemotherapy
- Zhongbo Hu,
- Kristen VanHeyst,
- Jignesh Dalal,
- Lisa Hackney
Kristen VanHeyst
UH Rainbow Babies and Children's Hospital
Author ProfileAbstract
DS-ALL patients have a higher rate of relapse and treatment-related
mortality. We describe a DS-ALL patient with late bone marrow relapse
who was treated per British ALL R3 reinduction chemotherapy. The patient
remained in remission for approximately two years after therapy was
discontinued due to severe systemic infections.05 Sep 2020Submitted to Clinical Case Reports 07 Sep 2020Submission Checks Completed
07 Sep 2020Assigned to Editor
13 Sep 2020Reviewer(s) Assigned
21 Oct 2020Review(s) Completed, Editorial Evaluation Pending
28 Oct 2020Editorial Decision: Revise Minor
11 Nov 20201st Revision Received
16 Nov 2020Submission Checks Completed
16 Nov 2020Assigned to Editor
16 Nov 2020Review(s) Completed, Editorial Evaluation Pending
27 Nov 2020Editorial Decision: Accept
